Carmine N. Stengone, CEO and President at Contineum Therapeutics, Inc. (CTNM), sold 14,200 shares at $16.02 ($227K) on 2026-02-24, disclosed to the SEC on 2026-02-26.
Open-market sale of $227k CTNM by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.02 | 4,400 | $70K | 31.0% |
| 2 | $16.02 | 4,400 | $70K | 31.0% |
| 3 | $16.02 | 2,700 | $43K | 19.0% |
| 4 | $16.02 | 2,700 | $43K | 19.0% |
| Total | $16.02 avg | 14,200 | $227K | 100% |
| Filing → |
| CTNM | SELL | 2026-07-08 | $40K | — | Filing → |
| CTNM | SELL | 2026-07-01 | $160K | — | Filing → |
| CTNM | SELL | 2026-02-13 | $6K | — | Filing → |